Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sclerosing cholangitis.

E B Martins1, R W Chapman

  • 1Department of Clinical Medicine, Hospital Universitário, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. emartins@writeme.com

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of Uterine Polypus Removed by the Ligature, in Which Dilatation of the Os Uteri Was Produced by the Administration of the Lobelia Inflata.

Edinburgh medical and surgical journal·2018
Same author

Editorial: vancomycin - a promising option for the treatment of primary sclerosing cholangitis?

Alimentary pharmacology & therapeutics·2018
Same author

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.

Alimentary pharmacology & therapeutics·2016
Same author

Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging.

Alimentary pharmacology & therapeutics·2016
Same author

A rare cause of colonic thickening and lymphadenopathy.

Gut·2016
Same author

Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC.

Alimentary pharmacology & therapeutics·2014
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Primary sclerosing cholangitis (PSC) may have autoimmune or bacterial origins, with specific autoantibodies and Helicobacter spp. detected. Liver transplantation is the only effective treatment for this chronic cholestatic liver disease.

Area of Science:

  • Hepatology
  • Immunology
  • Microbiology

Background:

  • Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with potential autoimmune underpinnings.
  • Autoantibodies, including antineutrophil cytoplasmic antibodies targeting nuclear envelope proteins, are found in most PSC patients.
  • Evidence suggests a possible bacterial role, with Helicobacter gene sequences detected in liver tissues.

Purpose of the Study:

  • To explore the potential autoimmune and bacterial etiologies of PSC.
  • To review diagnostic methods and prognostic models for PSC.
  • To assess current treatment strategies for PSC.

Main Methods:

  • Review of existing literature on PSC pathogenesis, diagnosis, and treatment.
  • Analysis of autoantibody profiles in PSC patients.

Related Experiment Videos

  • Detection of bacterial gene sequences in liver tissues.
  • Main Results:

    • Circulating antineutrophil cytoplasmic antibodies against a 50-kD nuclear envelope protein are common in PSC.
    • Helicobacter spp. DNA has been identified in liver tissues of PSC patients.
    • Established prognostic models lack cross-validation, and several drug trials have shown no benefit.

    Conclusions:

    • The exact role of autoantibodies and bacteria in PSC pathogenesis requires further investigation.
    • Endoscopic retrograde cholangiography is the gold standard for diagnosis, with MRI as a viable alternative.
    • Orthotopic liver transplantation remains the sole effective treatment for primary sclerosing cholangitis.